NCT00894517

A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 61 (actual)
• Sponsor: Allergan · Industry
• Sex: Male
• Age: 45 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This is a 24 week study evaluating the effects of botulinum toxin Type A on semen quality in patients with signs and symptoms of Benign Prostatic Hyperplasia (BPH).

Conditions

• Benign Prostatic Hyperplasia

Interventions

Type	Name	Description
BIOLOGICAL	Botulinum Toxin Type A	OnabotulinumtoxinA (botulinum toxin Type A) 200U injected into the prostate on Day 1.
DRUG	Placebo (saline)	Saline injected into the prostate on Day 1.

Timeline

• Start date: 2009-08-01
• Primary completion: 2012-06-01
• Completion: 2012-08-01
• First posted: 2009-05-07
• Last updated: 2013-09-30
• Results posted: 2013-09-30

Locations

1 site across 1 country: United States